Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Parathyroid Disorders and Treatments

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the complex interplay of FGF23, phosphate, calcification, and mineral metabolism in the context of chronic kidney disease. It explores the role of parathyroid hormone, vascular health, and the impact of Klotho deficiency on mineral homeostasis. The cluster also delves into the implications of hyperphosphatemia and calcification on cardiovascular risk in patients with chronic kidney disease.

565
Works

How has Parathyroid Disorders and Treatments's publication output changed over time?

ScholarIQpublication output · 2000–2016

Output grew0% over the shown period — from 1 works in 2000 to 1 in 2016.

1
2
3
2
1
1
1
2
1
1
2000200220032004200620072008201120122016

What are the most-cited papers on Parathyroid Disorders and Treatments?

ScholarIQmost cited works
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Geoffrey A. Block, Preston Klassen, J. Michael Lazarus, Norma J. Ofsthun, Edmund G. Lowrie, Glenn M. Chertow
Journal of the American Society of Nephrology. 20042,694 Citations
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry, Jack W. Coburn, Glenn M. Chertow, Keith A. Hruska, Craig B. Langman, Hartmut H. Malluche, Kévin Martin, Linda McCann, James T. McCarthy, Sharon M. Moe, Isidro B. Salusky, Donald J. Sherrand, Miroslaw Smogorzewski, Kline Bolton, Charles M. Turkelson, Karyn A. Tappe, Stephen Tregear, James Reston, Wendy Bruening, Mark Monteforte, Janice L Kaczmarek, Vivian Coates, George R. Bailie, Bryan Becker, Gavin J. Becker, Jerrilynn D. Burrowes, Fernando Carrera, David Churchill, Alan Collins, Peter Crooks, Dick de Zeeuw, Thomas A. Golper, Frank A. Gotch, Antonio M. Gotto, Roger Greenwood, Joel Greer, Richard H. Grimm, William E. Haley, Ronald J. Hogg, Alan R. Hull, Lawrence G. Hunsicker, Cynda Ann Johnson, Michael J. Klag, Saulo Klahr, Norbert Lameire, Francesco Locatelli, Sally D. McCulloch, Maureen Michael, Joseph V. Nally, John M. Newmann, Allen R. Nissenson, Keith C. Norris, Gregorio T. Obrador, William F. Owen, Thakor G. Patel, Glenda M. Payne, Claudio Ronco, Rosa A. Rivera-Mizzoni, Anton C. Schoolwerth, Robert A. Star, Michael W. Steffes, Theodore I. Steinman, John Pierre Wauters, Nanette K. Wenger, Josephine P. Briggs, Thomas H. Hostetter, Garabed Eknoyan, Aderra Levin, Nathan W. Levin, Sharon Andreoli, S Burrows-Hudson, Derrick L. Latos, Donna Mapes, Edith T. Oberley, Brian J.G. Pereira, Nadine Ferguson, Donna Fingerhut, Anthony Gucciardo, Margaret Klette, Doreen Mallard, Kerry Willis
S4306401843. 20032,541 Citations
FGF23 induces left ventricular hypertrophy
Christian Faul, Ansel P. Amaral, Behzad N. Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mündel, Azorides R. Morales, Julia J. Scialla, Michael J. Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal A. Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro‐o, John W. Kusek, Martin Keane, Myles Wolf
S114430552. 20112,006 Citations
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
Kenneth E. White, W. Evans, Jeffery L.H. O'Riordan, Marcy C. Speer, Michael J. Econs, Bettina Lorenz‐Depiereux, Monika Grabowski, Thomas Meitinger, Tim M. Strom
S137905309. 20001,530 Citations
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
Adeera Levin, George L. Bakris, Mark E. Molitch, Maartje Smulders, Jianhua Tian, Laura Williams, D.L. Andress
Kidney International. 20061,515 CitationsOPEN ACCESS

Where is Parathyroid Disorders and Treatments research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Parathyroid Disorders and Treatments is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
0%
Green
7%
Hybrid
0%
Bronze
27%
Closed
67%

Related on ScholarIQ

Revised Equations for Estimated GFR From Serum Creatinine in Japan
Paper
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
Paper
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
Paper
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Paper
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Paper
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Paper
470M+ articles · free account